Lung Transplant - Pulmonary Fibrosis, Cystic Fibrosis, COPD, Pulmonary Hypertension and Bone Marrow
Wednesday, July 20, 2011
Article > InterMune's pirfenidone approved in Europe for IPF
Article > InterMune's pirfenidone approved in Europe for IPF
InterMune is celebrating after getting the thumbs-up from regulators in Europe for its idiopathic pulmonary fibrosis treatment Esbriet.
Thanks for the information Carolyn.
Celebrate Life,
Alma
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment